405 related articles for article (PubMed ID: 26651304)
1. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
Navajas EV; Krema H; Hammoudi DS; Lipton JH; Simpson ER; Boyd S; Easterbrook M
Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
[TBL] [Abstract][Full Text] [Related]
2. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
Marmor MF; Melles RB
Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Hydroxychloroquine Retinopathy.
Eldeeb M; Chan EW; Omar A
Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
[TBL] [Abstract][Full Text] [Related]
4. Perifoveal interdigitation zone loss in hydroxychloroquine toxicity leads to subclinical bull's eye lesion appearance on near-infrared reflectance imaging.
Chew AL; Sampson DM; Chelva E; Khan JC; Chen FK
Doc Ophthalmol; 2018 Feb; 136(1):57-68. PubMed ID: 29124422
[TBL] [Abstract][Full Text] [Related]
5. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
[TBL] [Abstract][Full Text] [Related]
6. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
Maturi RK; Yu M; Weleber RG
Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
[TBL] [Abstract][Full Text] [Related]
7. Subjective and objective screening tests for hydroxychloroquine toxicity.
Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
[TBL] [Abstract][Full Text] [Related]
8. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
[TBL] [Abstract][Full Text] [Related]
9. Threshold Amsler grid as a screening tool for asymptomatic patients on hydroxychloroquine therapy.
Almony A; Garg S; Peters RK; Mamet R; Tsong J; Shibuya B; Kitridou R; Sadun AA
Br J Ophthalmol; 2005 May; 89(5):569-74. PubMed ID: 15834087
[TBL] [Abstract][Full Text] [Related]
10. A possible early sign of hydroxychloroquine macular toxicity.
Brandao LM; Palmowski-Wolfe AM
Doc Ophthalmol; 2016 Feb; 132(1):75-81. PubMed ID: 26792426
[TBL] [Abstract][Full Text] [Related]
11. The multifocal pattern electroretinogram in chloroquine retinopathy.
Neubauer AS; Stiefelmeyer S; Berninger T; Arden GB; Rudolph G
Ophthalmic Res; 2004; 36(2):106-13. PubMed ID: 15017107
[TBL] [Abstract][Full Text] [Related]
12. Comparison between multifocal ERG and C-Scan SD-OCT ("en face" OCT) in patients with a suspicion of antimalarial retinal toxicity: preliminary results.
Arndt C; Costantini M; Chiquet C; Afriat M; Berthemy S; Vasseur V; Ducasse A; Mauget-Faÿsse M
Doc Ophthalmol; 2018 Apr; 136(2):97-111. PubMed ID: 29536324
[TBL] [Abstract][Full Text] [Related]
13. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
14. Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study.
Ruberto G; Bruttini C; Tinelli C; Cavagna L; Bianchi A; Milano G
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2201-2210. PubMed ID: 30151601
[TBL] [Abstract][Full Text] [Related]
15. Detection of Hydroxychloroquine Retinal Toxicity by Automated Perimetry in 60 Rheumatoid Arthritis Patients with Normal Fundoscopic Findings.
Motarjemizadeh Q; Aidenloo NS; Abbaszadeh M
Glob J Health Sci; 2015 Jun; 8(3):59-64. PubMed ID: 26493438
[TBL] [Abstract][Full Text] [Related]
16. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
[TBL] [Abstract][Full Text] [Related]
17. Comparison of screening procedures in hydroxychloroquine toxicity.
Marmor MF
Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
[TBL] [Abstract][Full Text] [Related]
18. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations.
Bulut M; Akıdan M; Gözkaya O; Erol MK; Cengiz A; Çay HF
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2075-2081. PubMed ID: 30159602
[TBL] [Abstract][Full Text] [Related]
20. VOLUMETRIC SINGLE-LAYER INNER RETINAL ANALYSIS IN PATIENTS WITH HYDROXYCHLOROQUINE TOXICITY.
Modi YS; Au A; Parikh VS; Ehlers JP; Schachat AP; Singh RP
Retina; 2016 Oct; 36(10):1941-50. PubMed ID: 27258672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]